T2 BiosystemsTTOO
13F holders, Q3 2024 (September 30)21holders
3new positions
2sold out
1famous investor
$1.97avg. 13F price*
At the end of Q3 2024, 21 institutions reported holding T2 Biosystems Inc. (TTOO) in their 13F filings, unchanged from Q2 2024. 3 opened new positions and 2 sold out. The largest holders were Armistice Capital, LLC ($2.8M), Vanguard Group Inc. ($769K) and Geode Capital Management, LLC ($179K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- T2 Biosystems Inc.
- CUSIP
- 89853L302
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $77K |
| Exits | 2 | $80 |
All 13F filers, Q2 2024 → Q3 2024: 121,916 shares bought and 319,322 shares sold, net −197,406 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Armistice Capital, LLC | 0.07% | Reduce -15.8% | 1,396,000 | $2.8M |
| Vanguard Group Inc. | 0.00% | Add +24.8% | 390,368 | $769K |
| Geode Capital Management, LLC | 0.00% | Reduce -30.3% | 90,880 | $179K |
| BlackRock, Inc. | 0.00% | — | 76,827 | $151K |
| State Street Corp. | 0.00% | No change | 63,743 | $126K |
| Susquehanna International Group, LLP | 0.00% | Add +9.2% | 45,481 | $90K |
| Millennium Management | 0.00% | New | 39,140 | $77K |
| Northern Trust Corp. | 0.00% | Reduce -30.2% | 27,142 | $53K |
| Goldman Sachs Group Inc. | 0.00% | Add +0.3% | 14,750 | $29K |
| Royal Bank of Canada | 0.00% | Add +40.1% | 4,001 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -68.7% | 2,399 | $5K |
| Cwm, LLC | 0.00% | No change | 310 | $1K |
| Group One Trading LLC | 0.00% | Reduce -71.4% | 289 | $569 |
| Osaic Holdings, Inc. | 0.00% | No change | 205 | $404 |
| Barclays PLC | 0.00% | New | 101 | $199 |
| Bank of America Corp. | 0.00% | Reduce -56.3% | 56 | $110 |
| International Assets Investment Management, LLC | 0.00% | No change | 33 | $65 |
| Morgan Stanley | 0.00% | No change | 14 | $28 |
| US Bancorp \de | 0.00% | No change | 3 | $6 |
| UBS Group AG | 0.00% | No change | 1 | $2 |
| IFP Advisors, Inc | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is TTOO's weight in each manager's 13F, not the share of T2 Biosystems Inc. the manager owns.